학술논문
Phase I Trial of Targeted Alpha-Particle Therapy with Actinium-225 (225Ac)-Lintuzumab and Low-Dose Cytarabine (LDAC) in Patients Age 60 or Older with Untreated Acute Myeloid Leukemia (AML)
Document Type
Abstract
Author
Source
In Blood 2 December 2016 128(22):4050-4050
Subject
Language
ISSN
0006-4971